Founded in 1975 as the all Union Research Institute of Applied Enzimology, currently,  the Institute of Biotechnology is mainly involved in research and training in the fields of biotechnology and molecular biology, including research and development of recombinant biomedical proteins, genetic and molecular studies of restriction modification phenomenon, developing of viruses diagnostics, epigenetic study of small RNA, drug design and synthesis, bioinformatics.

Current Grants

Spausdinti

 

FRAMEWORK 7 PROGRAMME

Title

Duration

Small Molecule Inhibitors Of The Trimeric Influenza Virus Polymerase Complex (FLUINHIBIT)

2008-2010

Cancer and Control of Genomic Integrity (CANGENIN).

2008-2012

Pan-European Network For The Study And Clinical Management Of Drug Resistant Tuberculosis ("TB PAN-NET")

2008-2013

Strengthening and Sustaining the European Perspectives of Molecular Biotechnology in Lithuania , MoBiLI

2009-2013

FRAMEWORK 6 PROGRAMME

Title

Duration

Meganucleases for Gene Replacement

2006-2008

A Multidisciplinary Approach to the Study of DNA Enzymes down to the Single Molecule Level

2005-2009

Targeting Newly Discovered Oxygen Sensing Cascades for Novel Cancer Treatments, Biology Equipment, Drugs

2004-2008

Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets

2006-2008

Rational Design and Comparative Evaluation of Novel Genetic Vaccines

2004-2008

HOWARD HUGHES MEDICAL INSTITUTE

Title

Duration

Structural characterization of protein interactions in DNA replication, repair and recombination processes through molecular modeling

2006-2010

OTHER INTERNATIONAL GRANTS

Title

Duration

European Economic Area - Anticancer compounds design by structural thermodinamycs

2008-2010

International Research Training Group - Enzymes and Multienzyme Complexes Acting on Nucleic Acids

2006-2010

National Institute of Health - Methylome Profiling via DNA Methyltransferase directed Labelling

2008-2009

EuroTB - Molecular surveillance of multi-drug resistant tuberculosis in Europe

2003-2008

 

NATIONAL GRANTS
Lithuanian Science and Studies Foundation

High-Technology Development Programme

Title

Duration

Generation of new systems for human Papilloma virus and cancer diagnosis in laboratory

2009-2011

Generation of humanized yeast expression systems via proteomics and gene engineering

2008-2010

New enzymes technologies for epigenome studies

2007-2009

Industrial Biotechnology Programme

Title

Duration

Generation of means for Merkel cell polyoma virus diagnosis

2009-2010

Technology development of bacterial cytolisins neutralizing proteins (antibodies) for therapy and diagnosis

2008-2010

Search for novel biofuel components and technological investigations to produce second generation biofuel

2007-2009

Design of technologies of recombinant proteins for prolonged therapy

2007-2009

Use of Biotechnological Methods For Carbonic Anhydrase Inhibitors Search

2007-2009

Engagement of metagenomic analysis of extremophile viruses from hot underground waters of Lithuania searching for the new enzymes

2007-2009

Detection Of Phytoplasmas And Viroids In Plants Valuable For Industrial Biotechnology And Their Removal

2007-2009